Cardiac Risk
Preventive Cardiology · Risk Assessment · Vashi

Cardiac Risk Assessment

Map your 10-year probability of myocardial infarction or stroke. We use calibrated SCORE2 algorithms to define clear baseline targets for cholesterol, lipids, and lifestyle metrics.

Clinical Author: Dr. Amit Singh, FACCCenter: Heartwise Cardiology Clinic, VashiMedical Review: May 2026
Preventive Profiling

The Cardiovascular Risk Factors

Risk markers are divided into modifiable variables that respond directly to therapy, and non-modifiable genetic variables.

The Cardiovascular Risk Factors

Cardiovascular disease develops 5–10 years earlier in the South Asian population compared to Western demographics. Visualising and quantifying modifiable factors — such as LDL cholesterol, blood pressure, HbA1c levels, and visceral fat — is the initial step to prevention. The SCORE2 algorithm, calibrated for high-risk regions including India, estimates 10-year risk of first cardiovascular event.

Modifiable & Non-Modifiable

Causes & Risk Factors for Heart Disease

Understanding your specific risk factor profile is the foundation of effective cardiovascular prevention.

Dyslipidemia

Elevated LDL cholesterol and triglycerides are primary drivers of atherosclerosis. Each 1 mmol/L reduction in LDL lowers cardiovascular risk by approximately 22%.

Hypertension

Elevated blood pressure damages arterial endothelium and accelerates plaque formation. Each 20 mmHg rise in systolic BP doubles cardiovascular mortality risk.

Diabetes Mellitus

Diabetes confers a 2–4 fold increased risk of cardiovascular disease. HbA1c levels above 7% significantly increase microvascular and macrovascular complications.

Obesity & Metabolic Syndrome

BMI >23 kg/m² in Indian populations significantly increases cardiovascular risk. Central obesity (increased waist circumference) is particularly harmful.

Tobacco Use

Smoking and tobacco chewing are among the most potent modifiable risk factors. Smoking cessation reduces cardiovascular risk by 50% within one year.

Non-Modifiable Factors

South Asian ethnicity, family history of premature CVD, elevated Lipoprotein(a), advancing age, and chronic kidney disease are non-modifiable but quantifiable risk enhancers.

Risk Calculations

SCORE2: 10-Year Risk Classifications

SCORE2 predictions categorise 10-year fatal and non-fatal cardiovascular event risks into four tiers, setting active therapy pathways.

Risk Category10-Year RiskLDL Target
Low Risk<5%LDL <3.0 mmol/L (<116 mg/dL)
Moderate Risk5–10%LDL <2.6 mmol/L (<100 mg/dL)
High Risk10–20%LDL <1.8 mmol/L (<70 mg/dL)
Very High Risk>20%LDL <1.4 mmol/L (<55 mg/dL)
Targeted Care

The Complete Preventive Consultation Plan

A preventive consultation with Dr. Amit Singh incorporates specific structured deliverables.

10-Year Risk Mapping

Generates your precise, ethnic-calibrated SCORE2 rating, indicating absolute risk percentage for heart attack or stroke.

Advanced Lipid Profiling

Reviews total cholesterol, LDL, HDL, and triglycerides to establish personalised pharmacotherapy targets.

Therapeutic Guidance

Determines if statins, ezetimibe, or other cardiovascular therapeutics are clinically indicated based on risk category.

Vascular Load Tracking

Covers blood pressure logs, matching office readings against continuous tracking if hypertension is suspected.

Lifestyle Prescription

Structured diet adjustments targeting glycemic control, visceral fat reduction, and healthy fat swaps.

Monitoring Timelines

Prescribes follow-up intervals for repeat lipid panels and tracking based on risk category.

Biochemical Markers

Required Blood Tests & Diagnostics

Accurate risk mapping relies on biochemical profiling. Fasting tests should be completed before your consultation.

1

Fasting Lipid Profile

Measures total cholesterol, LDL, HDL, and triglycerides — the core cardiovascular risk metrics. Fasting for 10–12 hours ensures accurate results.

2

Fasting Glucose & HbA1c

Measures glycemic status and rules out undiagnosed type 2 diabetes. HbA1c reflects 3-month average blood sugar control.

3

Kidney Profile (eGFR, Creatinine)

Chronic kidney disease directly amplifies cardiovascular and structural risk. eGFR <60 mL/min/1.73m² increases risk category.

4

Thyroid Profile (TSH)

Thyroid dysfunction triggers secondary cholesterol spikes. TSH must be evaluated before initiating statin therapy.

5

hs-CRP & Lipoprotein(a)

Inflammatory and genetic risk markers. Lp(a) is elevated in 20–25% of Indians and is an independent genetic risk factor measured once per lifetime.

Consequences

Risks of Ignoring Cardiac Risk Factors

Unaddressed cardiovascular risk factors lead to preventable heart attacks, strokes, and premature death.

Premature Heart Attack

South Asians experience heart attacks 5–10 years earlier than other populations. Undiagnosed and untreated risk factors are the primary cause.

Ischaemic Stroke

Hypertension, diabetes, and atrial fibrillation — all detectable through risk assessment — are leading causes of stroke. Most strokes are preventable with risk factor control.

Progressive Atherosclerosis

Elevated LDL and hypertension silently accelerate plaque buildup in arteries. Once established, atherosclerosis is harder to reverse than prevent.

Sudden Cardiac Death

Untreated risk factors can lead to sudden cardiac death as the first manifestation of heart disease. Prevention is far more effective than treating established disease.

Management

Treatment Based on Risk Category

SCORE2 risk stratification determines the intensity of preventive therapy.

Statin Therapy

Moderate-to-high intensity statins are recommended based on risk category. Atorvastatin 20–80 mg or Rosuvastatin 10–40 mg are the primary agents.

Blood Pressure Control

Target BP <140/90 mmHg for most patients, and <130/80 mmHg for high-risk patients. Combination therapy is often needed.

Lifestyle Modification

Dietary changes, exercise prescription, and weight management form the foundation of preventive therapy, reducing risk by 30–50% when consistently followed.

Diabetes Management

Glycemic control with HbA1c target <7% reduces microvascular and macrovascular complications. SGLT2 inhibitors and GLP-1 agonists offer cardiovascular benefit.

Pharmacotherapy

Preventive Cardiovascular Medications

Medication selection is guided by risk category, lipid profile, and individual patient factors.

Risk CategoryRecommended TherapyLDL Target
Low Risk (<5%)Lifestyle modification. Statin not routinely indicated.LDL <3.0 mmol/L
Moderate Risk (5–10%)Lifestyle intensification. Consider statin if LDL >3.0 mmol/L or risk enhancers present.LDL <2.6 mmol/L
High Risk (10–20%)Moderate-intensity statin (Atorvastatin 20–40 mg). Add ezetimibe if LDL not at target.LDL <1.8 mmol/L
Very High Risk (>20%)High-intensity statin (Atorvastatin 80 mg). Ezetimibe added routinely. Consider PCSK9i if not at target.LDL <1.4 mmol/L
Lp(a) ElevatedStatin + optimise all other risk factors. PCSK9i may reduce Lp(a) modestly.Lp(a) target <50 mg/dL
Modification

Lifestyle Changes for Prevention

Lifestyle modification is the cornerstone of cardiovascular prevention at every risk level.

Dietary Pattern

Adopt a Mediterranean or DASH-style diet rich in fruits, vegetables, whole grains, legumes, nuts, and olive oil. Limit saturated fat, processed foods, and added sugars.

Physical Activity

At least 150 minutes per week of moderate-intensity aerobic exercise (brisk walking, cycling, swimming). Resistance training twice weekly adds additional benefit.

Weight Optimisation

Target BMI <23 kg/m² for Indian populations. Waist circumference <90 cm for men and <80 cm for women. Each 5% weight loss improves multiple risk factors.

Tobacco Cessation

Complete tobacco cessation — including smoking and smokeless tobacco. Nicotine replacement therapy, counseling, and pharmacotherapy improve quit rates.

Standards

Prevention Guideline Standards

Cardiovascular prevention guidelines provide evidence-based frameworks for risk assessment and management.

GuidelineRecommendationClinical Impact
ESC 2021 PreventionSCORE2 risk estimation for all adults ≥40 years without established CVD. Risk category determines LDL targets and treatment intensity.Standardises prevention across Europe and high-risk regions including India
ACC/AHA 2019 Primary PreventionPooled Cohort Equations for 10-year risk. Statin indicated if risk ≥7.5% and LDL >1.8 mmol/L.US-based risk algorithm with different thresholds but similar treatment principles
Lipid Association of India 2020Aggressive LDL targets tailored for Indian populations. Very high risk LDL target <50 mg/dL.Recognises higher baseline risk in Indians and recommends more intensive therapy
ESC 2023 Focused UpdateNon-fasting lipid profile acceptable for initial screening. Lp(a) measurement recommended once in adults.Simplifies testing requirements and identifies genetic risk independently of LDL
Urgency

When to Schedule a Risk Assessment

Certain milestones and changes in health status warrant a formal cardiovascular risk evaluation.

Age 40 and Above

All adults aged 40 and above should have a baseline cardiac risk assessment, even without symptoms. This establishes your starting point for preventive care.

New Diagnosis of Hypertension or Diabetes

A newly diagnosed condition automatically increases cardiovascular risk. A formal risk assessment quantifies the combined risk and guides treatment intensity.

Family History of Heart Disease

If a first-degree relative (parent, sibling) had a heart attack or stroke before age 55 (male) or 65 (female), early and more frequent risk assessment is recommended.

Symptoms Despite Normal Screening

Chest pain, unusual breathlessness, palpitations, or reduced exercise tolerance warrant further evaluation regardless of calculated risk score.

Patient FAQs

Frequently Asked Questions

Detailed, peer-reviewed answers to the most common patient concerns regarding preventive cardiology.

A cardiac risk assessment is a structured 30–45 minute consultation that calculates your 10-year probability of heart attack or stroke using the SCORE2 algorithm (recommended in the 2021 ESC Cardiovascular Prevention Guidelines). It reviews your blood pressure, cholesterol, blood sugar, smoking status, family history, and lifestyle — identifies which risk factors are elevated — and produces a personalised prevention plan including diet changes, exercise prescription, and specific medication recommendations if indicated. Prevention is always more effective than treatment after the event.

A cardiac risk assessment is recommended for: all adults aged 40 and above as a routine preventive check; adults aged 30–39 with diabetes, hypertension, or a family history of premature heart disease; anyone with two or more cardiovascular risk factors (high cholesterol, hypertension, smoking, diabetes, obesity); people with a first-degree relative who had a heart attack or stroke before age 55 (male) or 65 (female); patients newly diagnosed with hypertension or type 2 diabetes; and anyone wanting a comprehensive understanding of their cardiac risk profile.

SCORE2 (Systematic Coronary Risk Estimation 2) is the validated risk calculator recommended in the 2021 ESC Guidelines on Cardiovascular Disease Prevention. It estimates the 10-year risk of a first heart attack or stroke in adults without pre-existing cardiovascular disease, using age, sex, smoking status, systolic blood pressure, and cholesterol-to-HDL ratio. India is classified in the 'high cardiovascular risk region.' SCORE2 categories: Low (<5%), Moderate (5–10%), High (10–20%), Very High (>20%). Each category has specific LDL targets and treatment intensity guidelines.

The essential blood tests are: fasting lipid profile (total cholesterol, LDL, HDL, triglycerides), fasting blood glucose, HbA1c (3-month average blood sugar), kidney function (creatinine, eGFR), and thyroid function (TSH — hypothyroidism causes secondary high cholesterol). Additional recommended tests include high-sensitivity CRP (hs-CRP) and lipoprotein(a) — Lp(a) — which is elevated in approximately 20–25% of Indians and is an independent genetic cardiovascular risk factor not detected by standard cholesterol tests. Blood tests should ideally be done fasting for the most accurate lipid and glucose measurements.

For low-risk individuals (<5% SCORE2), reassessment every 5 years is appropriate. For moderate risk (5–10%), reassess every 1–3 years depending on the number of risk factors. For high or very high risk individuals, annual review is recommended to monitor response to therapy and adjust treatment targets. If you start a new medication or experience a change in health status (new diagnosis of diabetes or hypertension), earlier reassessment is warranted. Your cardiologist will advise an individualised follow-up schedule.

Yes, significantly. Lifestyle modification can reduce cardiovascular risk by 30–50% when consistently applied. The INTERHEART study showed that nine modifiable risk factors account for over 90% of the population-attributable risk of myocardial infarction worldwide. Adopting a heart-healthy diet, achieving regular physical activity, maintaining healthy weight, and avoiding tobacco can substantially lower your SCORE2 risk category. For example, quitting smoking alone reduces cardiovascular risk by 50% within one year, and 10 kg weight loss can reduce systolic BP by 5–10 mmHg.

Lipoprotein(a) — Lp(a) — is a genetically determined lipoprotein similar to LDL but with an additional protein (apolipoprotein(a)) attached. High Lp(a) levels (>50 mg/dL or >125 nmol/L) are an independent risk factor for cardiovascular disease and aortic stenosis. Importantly, Lp(a) is largely determined by genetics and is not significantly altered by diet, exercise, or statins. Approximately 20–25% of Indians have elevated Lp(a), making it a particularly relevant risk factor in our population. Lp(a) is measured once per lifetime, and elevated levels may warrant more aggressive LDL lowering and risk factor control.

Heart age is a risk communication tool that translates your cardiovascular risk profile into an equivalent age. For example, a 45-year-old smoker with hypertension and elevated cholesterol may have a heart age of 60 — meaning their risk of heart attack or stroke equals that of a healthy 60-year-old. The concept makes risk more tangible and motivates lifestyle change. Heart age is calculated from the same risk factors used in SCORE2: age, sex, blood pressure, cholesterol, smoking status, and diabetes. Reducing your heart age through risk factor modification is a powerful prevention goal.

Clinical Philosophy

Advanced cardiovascular care. Restoring life, rhythm, and vitality.

Dr. Amit Singh, FACC
Consultant
Dr. Amit Singh, FACC

Consultant Interventional Cardiologist

Book a Visit.

Pick a date and time that works for you.

Select a date

June 2026
Online Scheduling

Book an Appointment with Dr. Amit Singh, FACC.

Schedule a cardiology consultation at Heartwise Clinic in Vashi, Navi Mumbai — online booking, WhatsApp, or call. Dr. Amit Singh offers in-clinic and secure video teleconsultations for patients across India and internationally.

1

Choose Date & Time

Pick a slot that fits your schedule from available morning or evening appointments.

2

Share Your Details

Provide your name, contact number, and a brief note about your cardiac concern or reason for visit.

3

Get Confirmed

Our clinical team confirms your slot within 24 hours via call or WhatsApp with pre-visit instructions.

4

Consult In-Clinic or Online

Visit Heartwise Clinic in Vashi or join a secure HD video teleconsultation from anywhere.

Consultation Options

In-Clinic Consultation

Kokilaben Hospital, Kopar Khairane & Heartwise Clinic, Vashi

HD Video Teleconsultation

Available pan-India and for international patients

WhatsApp Booking

Quick booking via +91 97695 17636 — reports & follow-ups

RK
PS
AP
MJ

100+ appointments this month

Confirmed by our clinical team

4.9 / 5 rating

From patient reviews

Clinical Locations

Our Cardiology
Centers.

Dr. Amit Singh consults across multiple flagship centers and outreach clinics in Navi Mumbai & Dombivli to ensure specialized, top-tier cardiac care is directly accessible.

Private Clinic

Our primary private cardiology clinic located in the heart of Vashi. Fully equipped for comprehensive heart health evaluations, non-invasive cardiac testing, and personalized consultations with Dr. Amit Singh in a comfortable and private setting.

OPD HoursMon – Sat: 9:00 AM – 8:00 PM
Hospital Attachment

Dr. Amit Singh is a key consultant at Kokilaben Dhirubhai Ambani Hospital, providing access to world-class infrastructure, advanced cath labs, and intensive care units for complex cardiac interventions and emergencies.

OPD HoursMon – Sat: 8:00 AM – 6:00 PM
Outreach Clinic

Bringing specialized heart care closer to you. Our Palava outreach clinic ensures that residents of Palava City and Dombivli have access to top-tier cardiac consultations without having to travel far.

OPD HoursMon, Wed, Fri (Session basis)
Outreach Clinic

Located in the rapidly developing node of Ulwe, our outreach clinic at Deepisha Medical Centre provides comprehensive cardiology evaluations and follow-ups for our patients in the region.

OPD HoursTue, Thu, Sat (Session basis)

Navi Mumbai Sectors & Surrounding Nodes Served

VashiKopar KhairaneNerulSanpadaSeawoodsCBD BelapurGhansoliTurbheAiroliKhargharPanvelKamotheUlweKalamboliTalojaJuinagar

Triple ESC & FACC Certified

International guidelines and clinical safety protocols applied across all heart centers.

99% Success Rate

Beat Better. Live Wiser.

Dr. Amit Singh, FACC

Dr. Amit Singh, FACC

Consultant Interventional Cardiologist

Medical Disclaimer: This article has been written and reviewed by Dr. Amit Singh, FACC, for educational purposes only. It does not constitute personalised medical advice and should not be used as a substitute for a consultation with a qualified cardiologist. Individual clinical decisions must be made by a treating physician based on complete medical history and examination. If you are experiencing chest pain, breathlessness, or other cardiac symptoms, seek emergency medical care immediately.